By Hailey Konnath ( April 28, 2021, 9:58 PM EDT) -- Pharmaceutical giant GlaxoSmithKline PLC on Wednesday threw its support behind Amgen in a patent dispute over the cholesterol medication Repatha, telling the Federal Circuit that a panel's decision earlier this year finding that the patents covering the drug are too broad to be enabled threatens to "devastate" innovation....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.